Connor, Clark & Lunn Investment Management (CC&L)’s Oramed Pharmaceuticals ORMP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136K | Sell |
60,449
-26,687
| -31% | -$60K | ﹤0.01% | 1442 |
|
|
2025
Q1 | $186K | Sell |
87,136
-19,926
| -19% | -$42.6K | ﹤0.01% | 1334 |
|
|
2024
Q4 | $259K | Sell |
107,062
-4,457
| -4% | -$10.8K | ﹤0.01% | 1281 |
|
|
2024
Q3 | $272K | Buy |
+111,519
| New | +$272K | ﹤0.01% | 1269 |
|
|
2022
Q1 | – | Sell |
-50,786
| Closed | -$725K | – | 1164 |
|
|
2021
Q4 | $725K | Buy |
50,786
+24,932
| +96% | +$356K | ﹤0.01% | 727 |
|
|
2021
Q3 | $568K | Buy |
+25,854
| New | +$568K | ﹤0.01% | 746 |
|